I now have sufficient information to provide a thorough, well-structured response. Here is the full interpretation and treatment plan:
Ultrasound Report Interpretation
Patient: Mrs. Nazhath Jabeen, 45 years, Female
Date: 04.08.2026 | Referral: Dr. Gowtham Gowda
Key Findings
| Parameter | Finding | Clinical Significance |
|---|
| Uterus size | 15.7 x 9.1 x 14.0 cm | Significantly bulky (normal: ~8 x 4 x 4 cm) |
| Largest fibroid | ~10.3 x 7.3 x 6.7 cm | Large intramural fibroid, right lateral + anterior wall, lower uterine segment |
| Fibroid type | Multiple anterior + posterior intramural fibroids | Intramural fibroids cause endometrial distortion and are directly responsible for HMB |
| IUCD | In situ | Copper IUCD likely - itself a cause of heavy bleeding |
| Endometrial fluid | Mild endometrial fluid noted | Can indicate intrauterine pathology or obstruction; needs attention |
| Endometrial thickness | 6 mm | Normal (acceptable range for reproductive age) |
| Ovaries | Right: 3.4 x 2.2 cm (normal); Left: obscured by bowel gas | No adnexal mass; no free fluid in POD |
Clinical Summary
This 45-year-old woman has a bulky uterus with multiple large intramural fibroids (largest ~10 cm) as the primary structural cause of her heavy menstrual bleeding. There is also a copper IUCD in situ, which independently worsens menstrual bleeding. The combination of large fibroids + copper IUCD in a perimenopausal woman is a classic recipe for severe menorrhagia and likely iron deficiency anaemia.
The mild endometrial fluid warrants consideration - it may reflect blood pooling around the IUCD or partial cavity obstruction by the lower segment fibroid. Endometrial pathology (hyperplasia/malignancy) must be excluded given her age.
Treatment Recommendations
Step 1 - Immediate Actions (Before Definitive Treatment)
-
Remove the IUCD - The copper IUCD independently increases menstrual blood loss by 30-50%. Removing it is a simple, immediate intervention that may reduce bleeding on its own.
-
Bloods: Full blood count (check for anaemia), serum ferritin, iron studies, coagulation screen, thyroid function.
-
Endometrial sampling / hysteroscopy: Given age 45, mild endometrial fluid, and the IUCD in situ, an endometrial biopsy (Pipelle) or diagnostic hysteroscopy is advisable to exclude endometrial hyperplasia or malignancy before any hormonal treatment.
-
If anaemic: Start oral iron supplementation (ferrous sulphate 200 mg TDS). For severe anaemia (Hb <9 g/dL), IV iron infusion is more effective - as noted in Berek & Novak's Gynecology.
Step 2 - Medical Management (Fertility-Sparing / Conservative First-Line)
| Drug | Mechanism | Dose | Notes |
|---|
| Tranexamic acid | Antifibrinolytic - reduces blood loss ~40-50% | 500-1000 mg TDS during menses | First-line symptomatic; no hormonal effect |
| NSAIDs (mefenamic acid, naproxen) | Reduces PG-mediated bleeding and dysmenorrhoea | Mefenamic acid 500 mg TDS during menses | Also helps pelvic discomfort |
| Combined OCP | Hormonal cycle control, reduces blood loss | 21-day cycle | Use cautiously at 45 yrs; check CVD risk |
| GnRH agonist (leuprolide, triptorelin) | Induces pseudo-menopause; shrinks fibroids ~30-50% | IM monthly, max 6 months | Use as pre-operative treatment to shrink fibroid, correct anaemia, and facilitate surgery. Add-back HRT for bone protection. NOT a permanent solution. |
| Mifepristone (anti-progesterone) | Reduces fibroid size, controls bleeding | 5 mg daily for 6 months | Effective, but benefits are often transient - Goldman-Cecil Medicine |
| Oral GnRH antagonist (relugolix + E2 + norethindrone) | Reduces HMB while preserving bone density | Relugolix 40 mg OD | Newer option; approved for fibroid-related HMB |
A levonorgestrel IUS (Mirena) can reduce HMB from fibroids, but given the large uterine cavity (TS 14 cm), cavity distortion by the large lower segment fibroid may make insertion difficult and reduce efficacy.
Step 3 - Definitive / Surgical Options (Recommended at This Stage)
Given the patient's age (45 years, perimenopausal), large fibroid size (~10 cm), multiple fibroids, and severity of symptoms, surgery is strongly indicated. This is supported by both Bailey & Love's Surgery and Berek & Novak's Gynecology.
Option A: Hysterectomy (Recommended - Definitive)
- Laparoscopic or vaginal hysterectomy is the gold standard for definitive cure of fibroid-related HMB in women who have completed their family.
- At age 45 with multiple large fibroids, this is the most appropriate long-term solution.
- Ovaries can typically be conserved (bilateral salpingo-oophorectomy only if indicated).
Option B: Myomectomy (if uterus preservation desired)
- Open (abdominal) myomectomy is preferred given the large fibroid size and multiple fibroids.
- Laparoscopic myomectomy is technically challenging for a 10 cm fibroid but feasible in expert hands.
- Relieves symptoms in ~80% of women - Berek & Novak's Gynecology, p.518.
- Risk: fibroid recurrence in 26% of women with multiple fibroids.
Option C: Uterine Artery Embolization (UAE)
- Minimally invasive; good for women wishing to avoid surgery.
- Reduces fibroid bulk by 40-60%; controls HMB in ~85%.
- Not ideal if the patient may want future pregnancy.
- Post-procedure hysterectomy/myomectomy needed in ~17-26% within 5 years - Berek & Novak's Gynecology.
Option D: Radiofrequency Ablation / High-Intensity Focused Ultrasound (HIFU/MRgFUS)
- Minimally invasive fibroid ablation.
- Suitable for select cases; less effective for multiple large fibroids as seen here.
Summary: Best Treatment Path for This Patient
AGE 45 + Large fibroids (10 cm) + Multiple fibroids + Copper IUCD + HMB
- Remove IUCD immediately
- Endometrial biopsy to exclude hyperplasia/malignancy
- Correct anaemia with iron supplementation
- GnRH agonist x 3 months pre-operatively to shrink fibroid and restore Hb
- Definitive surgery:
- If family complete → Total laparoscopic hysterectomy (best outcome)
- If uterus preservation desired → Abdominal myomectomy
The endometrial fluid is a flag - hysteroscopy before any surgery is prudent to confirm there is no co-existing endometrial pathology, especially at age 45.
References:
- [Berek & Novak's Gynecology](Berek & Novak's Gynecology, p.518) - Surgical treatment options for fibroids
- [Goldman-Cecil Medicine](Goldman-Cecil Medicine, p.486) - Medical treatment of fibroids
- Bailey & Love's Short Practice of Surgery 28th Ed., p.1609 - Fibroid classification and management principles
- Vannuccini S et al. (2024) - Modern management of uterine fibroid-related abnormal uterine bleeding, Fertil Steril
Disclaimer: This interpretation is for clinical decision-support. Final management must be tailored by the treating gynaecologist based on the patient's full history, examination findings, fertility wishes, and co-morbidities.